Related Experiment Videos
Automutilation induced by clonidine in mice
European Journal of Pharmacology
|February 1, 1975
Summary
Clonidine, a medication, induced self-harming behaviors in mice when housed alone. This automutilation effect persisted with chronic use and was absent in group-housed mice, suggesting environmental factors influence drug response.
Area of Science:
- Pharmacology
- Neuroscience
- Animal Behavior
Background:
- Clonidine (2-(2,6-dichlorophenylamino)-2-imidazoline hydrochloride, St155, Catapres) is an imidazoline derivative used clinically.
- Understanding drug-induced behaviors is crucial for assessing safety and efficacy.
- Environmental factors can significantly modulate behavioral responses to pharmacological agents.
Purpose of the Study:
- To investigate the behavioral effects of a single large dose of clonidine in mice.
- To determine if chronic administration of clonidine alters its behavioral effects.
- To assess the influence of housing conditions (individual vs. group) on clonidine-induced behaviors.
Main Methods:
- Administration of a single large dose of clonidine to individually housed mice.
- Chronic administration of clonidine to mice.
- Observation and recording of automutilation behavior in individually and group-housed mice.
- Comparison of behavioral responses between different dosing regimens and housing conditions.
Main Results:
- A single large dose of clonidine induced automutilation in individually housed mice.
- Chronic administration of clonidine did not significantly alter the observed automutilation.
- No automutilation behavior was observed in group-housed mice treated with clonidine.
- The presence of objects to bite did not prevent clonidine-induced automutilation in individually housed mice.
Conclusions:
- Clonidine can induce automutilation in mice, particularly under conditions of social isolation.
- Environmental context, specifically social housing, plays a critical role in modulating clonidine's behavioral effects.
- The findings highlight the importance of considering housing conditions in preclinical drug testing for behavioral side effects.